MDNLX | RBCUX | MDNLX / RBCUX | |
Total Expense Ratio | 0.76 | 0.41 | 185% |
Annual Report Gross Expense Ratio | 0.81 | 0.57 | 142% |
Fund Existence | 31 years | 8 years | - |
Gain YTD | -1.964 | -0.889 | 221% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.2B | 5.78B | 107% |
Annual Yield % from dividends | 3.29 | 3.65 | 90% |
Returns for 1 year | 0.53 | 1.52 | 35% |
Returns for 3 years | 2.65 | 4.14 | 64% |
Returns for 5 years | 2.57 | 0.04 | 6,009% |
Returns for 10 years | 12.75 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYMVX | 63.20 | 0.69 | +1.10% |
Rydex S&P MidCap 400 Pure Value A | |||
EPDIX | 10.93 | 0.05 | +0.46% |
EuroPac International Dividend Income I | |||
NQVRX | 50.87 | 0.11 | +0.22% |
Nuveen Multi Cap Value I | |||
BPAIX | 28.88 | 0.06 | +0.21% |
Boston Partners All Cap Value Instl | |||
JHBCX | 52.36 | -0.23 | -0.44% |
JHancock Blue Chip Growth NAV |